← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 27, 2022Last known activity
Aug 26, 2025
Timeline
2020s
- Jan 1, 2020
Evommune, Inc.— Founded
Drugs by trial phase (3 distinct, 6 trials)
Recent trials (7)
- NCT07150845Lead sponsorPhase 2Aug 26, 2025
- NCT06873516Lead sponsorPhase 2Mar 31, 2025
- NCT06723405Lead sponsorPhase 2Feb 28, 2025
- NCT06645821CollaboratorEarly Phase 1Nov 30, 2024
- NCT06603220Lead sponsorPhase 2Aug 14, 2024
- NCT05579899Lead sponsorPhase 2Sep 27, 2022
- NCT05579899Study directorPhase 2Sep 27, 2022
Details
- Founded
- Los Altos, US Jan 1, 2020
- Last known activity
- Aug 26, 2025